Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

NCT00191048 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention-Deficit/Hyperactivity Disorder
Comorbid Dyslexia

Interventions

DRUG: Atomoxetine

Sponsor

Eli Lilly and Company